Correction: Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-07-09
Metadata
Show full item recordCitation
Correction: Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE. Lupus Sci Med. 2020;7(1):e000398corr1. doi:10.1136/lupus-2020-000398corr1Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAdditional Links
https://lupus.bmj.com/content/7/1/e000398corr1.longhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351274/
ae974a485f413a2113503eed53cd6c53
10.1136/lupus-2020-000398corr1
Scopus Count
Collections
Related articles
- Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE.
- Authors: Nived O, Ingvarsson RF, Jöud A, Linge P, Tydén H, Jönsen A, Bengtsson AA
- Issue date: 2020 Jun
- Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus.
- Authors: Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW
- Issue date: 2000 Mar
- Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
- Authors: Demir S, Artim-Esen B, Şahinkaya Y, Pehlivan Ö, Alpay-Kanıtez N, Omma A, Erer B, Kamalı S, Gül A, Aral O, Öcal L, İnanç M
- Issue date: 2016 Feb
- Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
- Authors: Tarr T, Papp G, Nagy N, Cserép E, Zeher M
- Issue date: 2017 Feb
- High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.
- Authors: Mok CC, Birmingham DJ, Ho LY, Hebert LA, Rovin BH
- Issue date: 2013 Mar